Williams Jones Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Williams Jones Wealth Management's DGX Position: Q4 2022 in Review
Williams Jones Wealth Management sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 2,194 shares — an estimated $269K sold.
Williams Jones Wealth Management first reported a position in DGX in Q2 2020 and held it in 10 quarters. The position peaked at $915K in Q4 2021. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.
- Williams Jones Wealth Management reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
- Williams Jones Wealth Management sold 2,194 Quest Diagnostics shares in Q4 2022, an estimated $269K.
- Williams Jones Wealth Management first reported a position in Quest Diagnostics in Q2 2020 and held it in 10 quarters.
- Williams Jones Wealth Management's Quest Diagnostics position peaked at $915K in Q4 2021.
- 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.
Based on Williams Jones Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.